Clinical Trial Update: Aeson TAH System - Post-Market Clinical Follow-up Study

View source ↗

Summary

Carmat SAS reports a post-market clinical follow-up study of the Aeson Total Artificial Heart system, with recruitment ongoing to monitor safety and performance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aeson TAH System

Snippet

Sponsor: Carmat SAS | Conditions: Heart Failure | Status: RECRUITING